Viewing Study NCT00035204


Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2026-05-28 @ 11:57 AM
Study NCT ID: NCT00035204
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2002-05-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Donepezil View
None Alzheimer's View
None Dementia View
None Cognitive impairment View
None Aricept View
None Alzheimer's disease View
None Razadyne View
None Galantamine View